21st Aug 2009 17:04
Financial Services Authority
GlaxoSmithKline plc received on 21 August 2009 from Legal & General Group plc a notification of interests in GlaxoSmithKline plc Ordinary shares of 25 pence each, dated on 19 August 2009. This notice is given in accordance with DTR 5.8.12. |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
GlaxoSmithKline Plc |
|||
2. Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached. |
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||||
An event changing the breakdown of voting rights |
||||
Other (please specify): |
||||
3. Full name of person(s) subject to the notification obligation: |
Legal & General Group Plc (Group) Legal & General Investment Management Limited (LGIM) |
|||
4. Full name of shareholder(s) (if different from 3.): |
Legal & General Assurance (Pensions Management) Limited (PMC) Legal & General Group Plc (L&G) |
|||
5. Date of the transaction and date on which the threshold is crossed or reached: |
19 August 2009 |
|||
6. Date on which issuer notified: |
21 August 2009 |
|||
7. Threshold(s) that is/are crossed or reached: |
Below 5% (Group) Below 5% (LGIM) |
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares |
||||||||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
||||||||||||
Direct |
Indirect |
Direct |
Indirect |
|||||||||||||
ORD GBP 0.25 |
260,231,752 |
260,231,752 |
Below 5% |
|||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|||||||||||
Nominal |
Delta |
|||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
Below 5% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
|||||||||||||||||||||||
|
|||||||||||||||||||||||
Proxy Voting: |
|||||||||||||||||||||||
10. Name of the proxy holder: |
N/A |
||||||||||||||||||||||
11. Number of voting rights proxy holder will cease to hold: |
N/A |
||||||||||||||||||||||
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
||||||||||||||||||||||
13. Additional information: |
Notification using the total voting rights figure of 5,188,446,713 |
||||||||||||||||||||||
14. Contact name: |
Helen Lewis (LGIM) |
||||||||||||||||||||||
15. Contact telephone number: |
020 3124 3851 |
Related Shares:
GlaxosmithklineLegal & General